BioRestorative Therapies (BRTX) Return on Equity (2016 - 2025)
Historic Return on Equity for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to 4.12%.
- BioRestorative Therapies' Return on Equity fell 29500.0% to 4.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.12%, marking a year-over-year decrease of 29500.0%. This contributed to the annual value of 1.25% for FY2024, which is 2500.0% up from last year.
- Per BioRestorative Therapies' latest filing, its Return on Equity stood at 4.12% for Q3 2025, which was down 29500.0% from 2.38% recorded in Q2 2025.
- Over the past 5 years, BioRestorative Therapies' Return on Equity peaked at 8.44% during Q1 2021, and registered a low of 4.12% during Q3 2025.
- In the last 5 years, BioRestorative Therapies' Return on Equity had a median value of 1.67% in 2025 and averaged 0.68%.
- In the last 5 years, BioRestorative Therapies' Return on Equity soared by 79600bps in 2021 and then crashed by -96600bps in 2022.
- Over the past 5 years, BioRestorative Therapies' Return on Equity (Quarter) stood at 3.21% in 2021, then surged by 41bps to 1.89% in 2022, then increased by 23bps to 1.47% in 2023, then increased by 15bps to 1.25% in 2024, then crashed by -230bps to 4.12% in 2025.
- Its Return on Equity stands at 4.12% for Q3 2025, versus 2.38% for Q2 2025 and 1.67% for Q1 2025.